← Insider buys
RPRX

Royalty Pharma plc · Healthcare

EVP and CFO Terrance P. Coyne sold $2.7M of Royalty Pharma plc

Sold$2,669,172
$38.36Price
69,582Shares
−10%Stake

What RPRX did after the filing

Filed Dec 17Copier in Dec 18
The stock from Thu, Dec 18 open, $37.94
+12.2%
S&P 500, same days
+2.6%

Measured over 30 trading days, to the Feb 3 close.

Traded Mon, Dec 15. Filed Wed, Dec 17, 5:39 PM ET, after the close. Returns use the Dec 18 open and the Feb 3 close. Not investment advice.